Clinical Trials

360 enrolled

Urinary Bladder Neoplasms

NCT07398690 2026-03-17

INSIGHT-PCa

1,432 enrolled

Disease, Prostatic Neoplasms

NCT05725421 2026-03-16

Transplantation of Reconstructed Renal Allografts Following Ex-Vivo Partial Nephrectomy

5 enrolled

Carcinoma, Renal Cell

NCT06651632 2026-03-16

WATER IV PCa

280 enrolled

Prostatic Neoplasms

NCT06966778 2026-03-16

Oxybutynin ER to Promote Early Continence Recovery After Robotic Prostatectomy: A Randomized Controlled Trial

135 enrolled

Localized Prostate Cancer

NCT07130682 2026-03-16

PT2

35 enrolled

Prostate Cancer Patients Treated by Radiotherapy

NCT07245745 2026-03-16

Prospective Clinical Study Comparing PROMS After Adaptive or Conventional Radiotherapy in Prostate Cancer

188 enrolled

Prostatic Neoplasms

NCT07422597 2026-03-16

PRORAND

1,016 enrolled

Prostatic Neoplasms

NCT07302230 2026-03-13

EMPOWER

Urinary Bladder Neoplasms

NCT06511141 2026-03-12

Sacral Neuromodulation for Male Overactive Bladder (MOAB)

150 enrolled

Prostatic Hyperplasia, Prostatic Neoplasms, Urinary Bladder, Overactive

NCT06523634 2026-03-12

STEREOBED

284 enrolled

Prostatic Neoplasms

NCT07460843 2026-03-12

Comparison of TB+PB and TB+6SB for Prostate Cancer Diagnosis

592 enrolled

Disease, Prostatic Neoplasms

NCT04987086 2026-03-11

68Ga-PSMA PET in the Renal Cell Carcinoma

300 enrolled

Kidney Neoplasms, Neoplasm Metastasis

NCT06040125 2026-03-11

Debunking the Frailty-sarcopenIa-ADT Axis in mEtastatic Prostate canceR With multiComponent Exercise: The FIERCE Trial

80 enrolled

Prostatic Neoplasms

NCT06542757 2026-03-11

Evaluation of Tumor Control Based on Serial Multiparametric MRI and Post-Treatment Biopsies For Patients Treated With Dose Intensification to the Dominant Intra-Prostatic Lesion (DIL) Using Ultra-Hypofractionated, MR-Guided Radiotherapy

91 enrolled

Prostatic Neoplasms

NCT07461090 2026-03-11

Laparoscopic Versus Open Nephrectomy : Clinical Effectivness and Cost Analysis

60 enrolled

Carcinoma, Renal Cell

NCT07463508 2026-03-11

TG-BIL

20 enrolled

Testicular Neoplasms

NCT06456411 2026-03-10

Functional Near-Infrared Spectroscopy and Virtual Reality Relaxation Programs for Pain Management in Patients With Cancer

410 enrolled

BreastGenitourinary

Breast Neoplasms, Carcinoma, Carcinoma, Renal Cell

NCT07188064 2026-03-10

PRP NG PRO M

Prostatic Neoplasms

NCT04083937 2026-03-09

PAROS

897 enrolled

Prostatic Neoplasms

NCT05396872 2026-03-09

Patient Decision-making About Precision Oncology in Veterans With Advanced Prostate Cancer

250 enrolled

Prostatic Neoplasms

NCT07164456 2026-03-09

Together Stronger: A Family-centered Lifestyle Intervention for Black Prostate Cancer Survivors and Their Caregivers

648 enrolled

Family Centered

NCT06985238 2026-03-06

Stratagen Quantitative Prostate MRI Platform Pilot Study

75 enrolled

Prostatic Neoplasms

NCT04861194 2026-03-05

ERECT

70 enrolled

Prostatic Neoplasms

NCT05043012 2026-03-05

Diagnostic Performance Of Non-Endorectal Coil Multiparametric Magnetic Resonance Imaging Of Prostate With Flexible AIR Coil (DoNEMAC Study)

258 enrolled

Prostatic Neoplasms

NCT04705038 2026-03-04

Effect of Education on Treatment Decision Making for Patients With Prostate Cancer on Chronic Hormone Treatments

Prostatic Neoplasms

NCT05321316 2026-03-04

Nectin-4 Specific LMW PET Probe Imaging in Urothelial Carcinoma

20 enrolled

Carcinoma, Transitional Cell

NCT06171269 2026-03-04

Using MRI to Identify Areas to Receive Lower Doses of Radiation Treatment in Men With Prostate Cancerdose Mapping to Preserve Quality of Life

60 enrolled

Prostatic Neoplasms

NCT07187635 2026-03-03

Guiding Value of Urinary Tumor DNA Testing in Repeat Transurethral Resection of Non-Muscle-Invasive Bladder Cancer

196 enrolled

Urinary Bladder Neoplasms

NCT05608694 2026-03-02

MRI Screening in Men at High Risk of Developing Prostate Cancer

250 enrolled

Prostate Cancer Screening

NCT06040762 2026-03-02

A Home-Based Prehabilitation Exercise Intervention for Improving Physical Function in Patients With Bladder Cancer and Upper Tract Urothelial Cancer, Get Moving Trial

128 enrolled

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT05679557 2026-02-27

COMPETENCE

140 enrolled

Frailty, Urinary Bladder Neoplasms

NCT05948657 2026-02-27

ESCAPE

200 enrolled

Prostatic Neoplasms

NCT07436078 2026-02-27

Culturally Adapting an Intervention to Increase Genetic Testing in African American Cancer Survivors

GastrointestinalGenitourinary

85 enrolled

Prostatic Neoplasms, Colorectal Neoplasms

NCT05225428 2026-02-25

VERDI

BreastDermatologicGastrointestinalGenitourinaryGynecologicSarcoma

1,020 enrolled

Breast Neoplasms, Kidney Neoplasms, Melanoma, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma, Colorectal Neoplasms

NCT05879913 2026-02-25

ASCVD Management Using CCTA in Prostate Cancer Patients on ADT

Coronary Artery Disease, Prostatic Neoplasms

NCT07369570 2026-02-24

REMRI

Disease, Prostatic Neoplasms, Disease Progression

NCT07416630 2026-02-24

Web-Based Application for Monitoring Radiation Therapy Complications in Cancer Patients

30 enrolled

BreastGenitourinary

Breast Neoplasms, Urologic Neoplasms

NCT02871726 2026-02-23

Transrectal Ultrasound Robot-Assisted Prostate Biopsy

483 enrolled

Prostatic Neoplasms

NCT07426861 2026-02-23

PRO-ACT

80 enrolled

Postoperative Complications, Prostatic Neoplasms, Urinary Incontinence

NCT07042243 2026-02-20

The Florida ASCENT Study

BreastDermatologicGastrointestinalGenitourinaryOther hematologic neoplasmThoracic

Breast Neoplasms, Feeding Behavior, Food Preferences, Lung Neoplasms, Melanoma, Neoplasms, Prostatic Neoplasms, Skin Neoplasms, Colorectal Neoplasms, Hematologic Neoplasms, Malnutrition

NCT04556045 2026-02-19

Exercise Therapy and Radiation Therapy (EXERT) for Metastatic Prostate Cancer

80 enrolled

Motor Activity, Prostatic Neoplasms

NCT05590624 2026-02-19

Metabolic Impact of Prospective Controlled Mediterranean Type Diets on Prostate Cancer

30 enrolled

Prostatic Neoplasms

NCT07011342 2026-02-19

SCOUT

70 enrolled

Prostatic Neoplasms

NCT04983095 2026-02-17

METRO

118 enrolled

Prostate Cancer Metastatic

NCT05647564 2026-02-17

PET/CT Characterization of Treatment Resistance

25 enrolled

Prostatic Neoplasms

NCT06052683 2026-02-17

A Trial Evaluating Toxicity of SBRT and LDRB in Localized Prostate Cancer.

208 enrolled

Prostatic Neoplasms

NCT06303622 2026-02-17

Comparing MRI-Ultrasound Fusion and Cognitive-guided Biopsy for the Detection of csPCa: the PROFUSION Trial

1,250 enrolled